[Antihypoxic agents (review of the literature)].
D000086:Acetazolamide / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D001462:Barbital / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003580:Cytochromes / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005042:Etimizol / Q000627:therapeutic use; D005283:Fentanyl / Q000627:therapeutic use; D005958:Glucosephosphates / Q000627:therapeutic use; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D006885:Hydroxybutyrates / Q000627:therapeutic use; D000860:Hypoxia / Q000188:drug therapy*; D008773:Methylphenazonium Methosulfate / Q000627:therapeutic use; D008774:Methylphenidate / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D009536:Niacinamide / Q000627:therapeutic use; D010433:Pentylenetetrazole / Q000627:therapeutic use; D010629:Phenformin / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use
D003580:Cytochromes; D005958:Glucosephosphates; D006873:Hydroquinones; D006885:Hydroxybutyrates; D011437:Propylamines; D008774:Methylphenidate; D009536:Niacinamide; D008773:Methylphenazonium Methosulfate; D002110:Caffeine; D001462:Barbital; D004176:Dipyridamole; D009020:Morphine; D000324:Adrenocorticotropic Hormone; D000661:Amphetamine; D010629:Phenformin; D005042:Etimizol; D000086:Acetazolamide; D003975:Diazepam; D002746:Chlorpromazine; D005283:Fentanyl; D010433:Pentylenetetrazole; D004837:Epinephrine
Protivogipoksicheskie sredstva (obzor literatury).